Terms: = Kidney tumors AND KMT2C, ENSG00000055609, MLL3, 58508
14 results:
1. KMT2 Family of H3K4 Methyltransferases: Enzymatic Activity-dependent and -independent Functions.
Van HT; Xie G; Dong P; Liu Z; Ge K
J Mol Biol; 2024 Apr; 436(7):168453. PubMed ID: 38266981
[TBL] [Abstract] [Full Text] [Related]
2. Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma.
Pei J; Zhang J; Cong Q
FEBS Open Bio; 2024 Jan; 14(1):112-126. PubMed ID: 37964489
[TBL] [Abstract] [Full Text] [Related]
3. mll3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state.
Cui J; Zhang C; Lee JE; Bartholdy BA; Yang D; Liu Y; Erler P; Galbo PM; Hodge DQ; Huangfu D; Zheng D; Ge K; Guo W
Nat Cell Biol; 2023 Jan; 25(1):145-158. PubMed ID: 36604594
[TBL] [Abstract] [Full Text] [Related]
4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Analysis of Large-Scale Transcriptomes from Multiple Cancer Types.
Nong B; Guo M; Wang W; Songyang Z; Xiong Y
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946814
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.
Ishihara H; Yamashita S; Liu YY; Hattori N; El-Omar O; Ikeda T; Fukuda H; Yoshida K; Takagi T; Taneda S; Kondo T; Nagashima Y; Tanabe K; Ushijima T
Cancer Sci; 2020 Nov; 111(11):4276-4287. PubMed ID: 32860304
[TBL] [Abstract] [Full Text] [Related]
7. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N; Broun A; Ge K
Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
[TBL] [Abstract] [Full Text] [Related]
8. Acquired Cystic kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in kmt2c and TSC2 Genes.
Shah A; Lal P; Toorens E; Palmer MB; Schwartz L; Vergara N; Guzzo T; Nayak A
Am J Surg Pathol; 2020 Nov; 44(11):1479-1486. PubMed ID: 32604168
[TBL] [Abstract] [Full Text] [Related]
9. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from kidney Progenitor-Like Cells.
Saleeb RM; Farag M; Ding Q; Downes M; Bjarnason G; Brimo F; Plant P; Rotondo F; Lichner Z; Finelli A; Yousef GM
Am J Pathol; 2019 Oct; 189(10):2046-2060. PubMed ID: 31381885
[TBL] [Abstract] [Full Text] [Related]
10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
11.
Kim SH; Park WS; Chung J
Investig Clin Urol; 2019 May; 60(3):148-155. PubMed ID: 31098421
[TBL] [Abstract] [Full Text] [Related]
12. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.
Sarungbam J; Mehra R; Tomlins SA; Smith SC; Jayakumaran G; Al-Ahmadie H; Gopalan A; Sirintrapun SJ; Fine SW; Zhang Y; Amin MB; Reuter VE; Chen YB; Tickoo SK
Mod Pathol; 2019 May; 32(5):701-709. PubMed ID: 30622286
[TBL] [Abstract] [Full Text] [Related]
13. Histone H3 lysine 4 methyltransferase KMT2D.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract] [Full Text] [Related]
14. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Chen YB; Xu J; Skanderup AJ; Dong Y; Brannon AR; Wang L; Won HH; Wang PI; Nanjangud GJ; Jungbluth AA; Li W; Ojeda V; Hakimi AA; Voss MH; Schultz N; Motzer RJ; Russo P; Cheng EH; Giancotti FG; Lee W; Berger MF; Tickoo SK; Reuter VE; Hsieh JJ
Nat Commun; 2016 Oct; 7():13131. PubMed ID: 27713405
[TBL] [Abstract] [Full Text] [Related]
